{"transactions":[{"id":2799805,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2021-03-09T21:02:06.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":800,"price":86.7,"value":69360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020."}],"balance_after":73020,"source":{"system":"sec-edgar","filing":"0001209191-21-018932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121018932/doc4.xml","form_type":"4"}},{"id":2799804,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2021-03-09T21:02:06.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":2900,"price":85.5021,"value":247956.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents the weighted average sale price of the shares sold ranging from $84.99 to $85.81 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":73820,"source":{"system":"sec-edgar","filing":"0001209191-21-018932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121018932/doc4.xml","form_type":"4"}},{"id":2799803,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2021-03-09T21:02:06.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":2728,"price":84.2026,"value":229704.6928,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents the weighted average sale price of the shares sold ranging from $83.775 to $84.76 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":76720,"source":{"system":"sec-edgar","filing":"0001209191-21-018932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121018932/doc4.xml","form_type":"4"}},{"id":2799802,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2021-03-09T21:02:06.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":2480,"price":83.4635,"value":206989.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sale price of the shares sold ranging from $82.74 to $83.68 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":79448,"source":{"system":"sec-edgar","filing":"0001209191-21-018932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121018932/doc4.xml","form_type":"4"}},{"id":2799801,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2021-03-09T21:02:06.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":2993,"price":81.5985,"value":244224.3105,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price of the shares sold ranging from $81.19 to $82.15 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":81928,"source":{"system":"sec-edgar","filing":"0001209191-21-018932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121018932/doc4.xml","form_type":"4"}},{"id":2799800,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2021-03-09T21:02:06.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":5174,"price":80.7349,"value":417722.3726,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $80.12 to $81.09 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":84921,"source":{"system":"sec-edgar","filing":"0001209191-21-018932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121018932/doc4.xml","form_type":"4"}},{"id":2799799,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2021-03-09T21:02:06.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":4627,"price":79.5841,"value":368235.6307,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $79.09 to $80.08 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":90095,"source":{"system":"sec-edgar","filing":"0001209191-21-018932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121018932/doc4.xml","form_type":"4"}},{"id":2799798,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2021-03-09T21:02:06.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":3298,"price":78.6039,"value":259235.6622,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $78.08 to $79.02 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":94722,"source":{"system":"sec-edgar","filing":"0001209191-21-018932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121018932/doc4.xml","form_type":"4"}},{"id":2899093,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-22T23:19:56.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":5481,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in 48 equal monthly installments beginning on February 1, 2021 such that this option is fully exercisable on January 1, 2025."}],"balance_after":5481,"derivative":{"exercise_price":109.01,"expiration_date":"2031-01-20","underlying":"Common Stock","underlying_shares":5481},"source":{"system":"sec-edgar","filing":"0001209191-21-004954","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004954/doc4.xml","form_type":"4"}},{"id":2899092,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2021-01-22T23:19:56.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":14411,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award of restricted stock units (\"RSUs\") that vests with respect to the 1/4th of the underlying shares on each of January 8, 2022, January 8, 2023, January 8, 2024, and January 8, 2025."}],"balance_after":98020,"source":{"system":"sec-edgar","filing":"0001209191-21-004954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121004954/doc4.xml","form_type":"4"}},{"id":2909530,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2021-01-13T01:38:40.000Z","date":"2021-01-11","kind":"sale","acquired":false,"shares":871,"price":109.654,"value":95508.634,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the reporting person on January 8, 2020. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.19 to $110.18 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":83609,"source":{"system":"sec-edgar","filing":"0001209191-21-003338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003338/doc4.xml","form_type":"4"}},{"id":2909529,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2021-01-13T01:38:40.000Z","date":"2021-01-11","kind":"sale","acquired":false,"shares":1050,"price":110.758,"value":116295.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the reporting person on January 8, 2020. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.19 to $111.18 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":84480,"source":{"system":"sec-edgar","filing":"0001209191-21-003338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003338/doc4.xml","form_type":"4"}},{"id":2909528,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2021-01-13T01:38:40.000Z","date":"2021-01-11","kind":"sale","acquired":false,"shares":1332,"price":111.616,"value":148672.512,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 6,250 shares of Common Stock underlying RSUs granted to the reporting person on January 8, 2020. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.19 to $112.18 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":85530,"source":{"system":"sec-edgar","filing":"0001209191-21-003338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003338/doc4.xml","form_type":"4"}},{"id":2909527,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2021-01-13T01:38:40.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":151,"price":114.755,"value":17328.005,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 15,000 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.38 to $115.37 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":86862,"source":{"system":"sec-edgar","filing":"0001209191-21-003338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003338/doc4.xml","form_type":"4"}},{"id":2909526,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2021-01-13T01:38:40.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":872,"price":115.799,"value":100976.728,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 15,000 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.38 to $116.37 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":87013,"source":{"system":"sec-edgar","filing":"0001209191-21-003338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003338/doc4.xml","form_type":"4"}},{"id":2909525,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2021-01-13T01:38:40.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":2451,"price":117.154,"value":287144.454,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 15,000 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.38 to $117.37 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":87885,"source":{"system":"sec-edgar","filing":"0001209191-21-003338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003338/doc4.xml","form_type":"4"}},{"id":2909524,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2021-01-13T01:38:40.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":2755,"price":117.599,"value":323985.245,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 15,000 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.38 to $118.37 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":90336,"source":{"system":"sec-edgar","filing":"0001209191-21-003338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919121003338/doc4.xml","form_type":"4"}},{"id":2979573,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2020-11-16T22:12:40.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":14781,"price":52.3993,"value":774514.0533,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $51.96 to $52.88 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":93091,"source":{"system":"sec-edgar","filing":"0001209191-20-058492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120058492/doc4.xml","form_type":"4"}},{"id":2979572,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2020-11-16T22:12:40.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":5287,"price":51.603,"value":272825.061,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $50.95 to $51.93 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":107872,"source":{"system":"sec-edgar","filing":"0001209191-20-058492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120058492/doc4.xml","form_type":"4"}},{"id":2979571,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2020-11-16T22:12:40.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":4932,"price":50.3663,"value":248406.5916,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $49.91 to $50.90 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":113159,"source":{"system":"sec-edgar","filing":"0001209191-20-058492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120058492/doc4.xml","form_type":"4"}},{"id":3029973,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2020-09-16T20:01:08.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":5713,"price":37.1213,"value":212073.9869,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price of the shares sold ranging from $36.69 to $37.51 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":118091,"source":{"system":"sec-edgar","filing":"0001209191-20-050681","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120050681/doc4.xml","form_type":"4"}},{"id":3029972,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2020-09-16T20:01:08.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":17887,"price":36.1105,"value":645908.5135,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price of the shares sold ranging from $35.68 to $36.65 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":123804,"source":{"system":"sec-edgar","filing":"0001209191-20-050681","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120050681/doc4.xml","form_type":"4"}},{"id":3029971,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common stock","published_at":"2020-09-16T20:01:08.000Z","date":"2020-09-14","kind":"sale","acquired":false,"shares":1400,"price":35.3979,"value":49557.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $34.68 to $35.67 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":141691,"source":{"system":"sec-edgar","filing":"0001209191-20-050681","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120050681/doc4.xml","form_type":"4"}},{"id":3313256,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-10T21:01:04.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":90000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 1, 2020 such that this option is fully exercisable on January 1, 2024."}],"balance_after":90000,"derivative":{"exercise_price":21.99,"expiration_date":"2030-01-08","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-20-003025","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120003025/doc4.xml","form_type":"4"}},{"id":3313255,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-01-10T21:01:04.000Z","date":"2020-01-08","kind":"sale","acquired":false,"shares":5700,"price":20.6993,"value":117986.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 15,000 shares of Common Stock underlying RSUs granted to the reporting person on January 7, 2019. This sale was made pursuant to an irrevocable election on November 20, 2019 by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.38 to $20.8850 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":143091,"source":{"system":"sec-edgar","filing":"0001209191-20-003025","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120003025/doc4.xml","form_type":"4"}},{"id":3313254,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-01-10T21:01:04.000Z","date":"2020-01-08","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award of restricted stock units (\"RSUs\") that vests with respect to 1/4 of the underlying shares on each of January 8, 2021, January 8, 2022, January 8, 2023, and January 8, 2024. This grant is subject to an accelerated vesting upon a change of control of the Issuer and in the event of termination of employment under certain circumstances following a change of control of the Issuer."}],"balance_after":148791,"source":{"system":"sec-edgar","filing":"0001209191-20-003025","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120003025/doc4.xml","form_type":"4"}},{"id":3327041,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-02T21:01:01.000Z","date":"2019-12-30","kind":"exercise","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2018 and modified on December 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 8, 2016 such that this option is fully exercisable on January 8, 2020."}],"balance_after":98800,"derivative":{"exercise_price":2.9,"expiration_date":"2026-01-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-000242","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120000242/doc4.xml","form_type":"4"}},{"id":3327040,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-01-02T21:01:01.000Z","date":"2019-12-30","kind":"sale","acquired":false,"shares":100,"price":20.34,"value":2034.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2018 and modified on December 10, 2018."}],"balance_after":123791,"source":{"system":"sec-edgar","filing":"0001209191-20-000242","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120000242/doc4.xml","form_type":"4"}},{"id":3327039,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-01-02T21:01:01.000Z","date":"2019-12-30","kind":"sale","acquired":false,"shares":24900,"price":19.4937,"value":485393.13,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2018 and modified on December 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $19.21 to $20.08 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":123891,"source":{"system":"sec-edgar","filing":"0001209191-20-000242","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120000242/doc4.xml","form_type":"4"}},{"id":3327038,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-01-02T21:01:01.000Z","date":"2019-12-30","kind":"exercise","acquired":true,"shares":25000,"price":2.9,"value":72500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2018 and modified on December 10, 2018."}],"balance_after":148791,"source":{"system":"sec-edgar","filing":"0001209191-20-000242","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120000242/doc4.xml","form_type":"4"}},{"id":3392867,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-10-16T20:04:55.000Z","date":"2019-10-15","kind":"sale","acquired":false,"shares":11800,"price":14.2875,"value":168592.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 33,000 shares of Common Stock underlying restricted stock units (\"RSUs\") granted to the reporting person on October 15, 2015. This sale was made pursuant to an irrevocable election on December 19, 2018 by the reporting person to satisfy tax withholding obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.94 to $14.59 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"All remaining shares of Common Stock held by the reporting person are subject to the terms of a lock-up agreement with Jefferies LLC and Citigroup Global Markets Inc. (the \"Representatives\"), as representatives of the underwriters in the Company's public offering pursuant to a prospectus supplement dated September 11, 2019, pursuant to which the reporting person agreed, without the prior written consent of the Representatives, and subject to limited exceptions, not to sell, offer to sell, contract to sell or lend, effect any short sale, pledge, hypothecate or grant any security interest in, or otherwise transfer or dispose of, any shares of Common Stock, either directly or indirectly."}],"balance_after":123791,"source":{"system":"sec-edgar","filing":"0001209191-19-053272","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919119053272/doc4.xml","form_type":"4"}},{"id":3476008,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-06-28T20:02:46.000Z","date":"2019-06-27","kind":"exercise","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2018 and modified on December 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 8, 2016 such that this option is fully exercisable on January 8, 2020."}],"balance_after":123800,"derivative":{"exercise_price":2.9,"expiration_date":"2026-01-07","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-19-039461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919119039461/doc4.xml","form_type":"4"}},{"id":3476007,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-06-28T20:02:46.000Z","date":"2019-06-27","kind":"sale","acquired":false,"shares":12500,"price":20.2088,"value":252610.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2018 and modified on December 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $19.65 to $20.47 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":135591,"source":{"system":"sec-edgar","filing":"0001209191-19-039461","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919119039461/doc4.xml","form_type":"4"}},{"id":3476006,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-06-28T20:02:46.000Z","date":"2019-06-27","kind":"exercise","acquired":true,"shares":12500,"price":2.9,"value":36250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2018 and modified on December 10, 2018."}],"balance_after":148091,"source":{"system":"sec-edgar","filing":"0001209191-19-039461","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919119039461/doc4.xml","form_type":"4"}},{"id":3573978,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-29T20:01:39.000Z","date":"2019-03-28","kind":"exercise","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2018 and modified on December 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 8, 2016 such that this option is fully exercisable on January 8, 2020."}],"balance_after":136300,"derivative":{"exercise_price":2.9,"expiration_date":"2026-01-07","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-19-021717","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919119021717/doc4.xml","form_type":"4"}},{"id":3573977,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-03-29T20:01:39.000Z","date":"2019-03-28","kind":"sale","acquired":false,"shares":12500,"price":16.9362,"value":211702.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2018 and modified on December 10, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold ranging from $16.71 to $17.30 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":135591,"source":{"system":"sec-edgar","filing":"0001209191-19-021717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919119021717/doc4.xml","form_type":"4"}},{"id":3573976,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-03-29T20:01:39.000Z","date":"2019-03-28","kind":"exercise","acquired":true,"shares":12500,"price":2.9,"value":36250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2018 and modified on December 10, 2018."}],"balance_after":148091,"source":{"system":"sec-edgar","filing":"0001209191-19-021717","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919119021717/doc4.xml","form_type":"4"}},{"id":3698995,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-09T21:01:53.000Z","date":"2019-01-07","kind":"grant","acquired":true,"shares":135000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 1, 2019 such that this option is fully exercisable on January 1, 2023."}],"balance_after":135000,"derivative":{"exercise_price":16.55,"expiration_date":"2029-01-06","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001209191-19-003019","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919119003019/doc4.xml","form_type":"4"}},{"id":3698994,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-01-09T21:01:53.000Z","date":"2019-01-07","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award of Restricted Stock Units that vests with respect to 1/3 of the underlying shares on each of January 7, 2020, January 7, 2021, and January 7, 2022. This grant is subject to an accelerated vesting upon a change of control of the Issuer and in the event of termination of employment under certain circumstances following a change of control of the Issuer."}],"balance_after":135591,"source":{"system":"sec-edgar","filing":"0001209191-19-003019","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919119003019/doc4.xml","form_type":"4"}},{"id":4097753,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-17T21:05:43.000Z","date":"2018-01-16","kind":"grant","acquired":true,"shares":186000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 16, 2018 such that this option is fully exercisable on January 16, 2022."}],"balance_after":186000,"derivative":{"exercise_price":6.55,"expiration_date":"2028-01-15","underlying":"Common Stock","underlying_shares":186000},"source":{"system":"sec-edgar","filing":"0001209191-18-003919","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919118003919/doc4.xml","form_type":"4"}},{"id":4184779,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-10-17T20:04:03.000Z","date":"2017-10-16","kind":"sale","acquired":false,"shares":700,"price":4.08,"value":2856.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 33,000 shares of Common Stock underlying restricted stock units (\"RSUs\") granted to the reporting person on October 15, 2015. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\"transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.97 to $4.17 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of Common Stock underlying RSUs granted to the reporting person, which are subject to certain vesting conditions."}],"balance_after":90591,"source":{"system":"sec-edgar","filing":"0001209191-17-057147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919117057147/doc4.xml","form_type":"4"}},{"id":4184778,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-10-17T20:04:03.000Z","date":"2017-10-13","kind":"sale","acquired":false,"shares":12525,"price":3.86,"value":48346.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 33,000 shares of Common Stock underlying restricted stock units (\"RSUs\") granted to the reporting person on October 15, 2015. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through a \"sell to cover\"transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.52 to $4.08 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes previously reported shares of Common Stock underlying RSUs granted to the reporting person, which are subject to certain vesting conditions."}],"balance_after":91291,"source":{"system":"sec-edgar","filing":"0001209191-17-057147","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919117057147/doc4.xml","form_type":"4"}},{"id":4496300,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":141612,"kind":"person","name":"Shoemaker Daniel D","position":1,"cik":"0001586892","reported_name":"Shoemaker Daniel D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-06T21:02:39.000Z","date":"2017-01-04","kind":"grant","acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 4, 2017 such that this option is fully exercisable on January 4, 2021."}],"balance_after":150000,"derivative":{"exercise_price":2.73,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-17-002630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919117002630/doc4.xml","form_type":"4"}}]}